USANA Health Sciences, Inc. (USNA) Shares Sold by Schwab Charles Investment Management Inc.

Schwab Charles Investment Management Inc. trimmed its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 7.8% during the third quarter, HoldingsChannel.com reports. The fund owned 84,857 shares of the company’s stock after selling 7,204 shares during the period. Schwab Charles Investment Management Inc.’s holdings in USANA Health Sciences were worth $4,897,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in USNA. BNP Paribas Arbitrage SA increased its stake in USANA Health Sciences by 13.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after buying an additional 245 shares during the period. Victory Capital Management Inc. increased its stake in USANA Health Sciences by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock worth $160,000 after buying an additional 373 shares during the period. SG Americas Securities LLC purchased a new stake in USANA Health Sciences during the 2nd quarter worth approximately $162,000. Legal & General Group Plc increased its stake in USANA Health Sciences by 7.6% during the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after buying an additional 284 shares during the period. Finally, Trust Co. of Vermont increased its stake in USANA Health Sciences by 482.7% during the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after buying an additional 3,900 shares during the period. 43.82% of the stock is currently owned by institutional investors and hedge funds.

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 1,710 shares of the stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $67.01, for a total value of $114,587.10. Following the sale, the director now directly owns 1,710 shares of the company’s stock, valued at approximately $114,587.10. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Global Ltd Gull sold 45,216 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $66.44, for a total transaction of $3,004,151.04. Following the completion of the sale, the insider now directly owns 11,694,053 shares in the company, valued at $776,952,881.32. The disclosure for this sale can be found here. Over the last three months, insiders sold 623,752 shares of company stock worth $41,411,372. Insiders own 53.20% of the company’s stock.

Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at $73.60 on Wednesday. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $76.15. The firm has a market cap of $1,780.00, a P/E ratio of 20.28 and a beta of 1.06.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, beating the Zacks’ consensus estimate of $0.91 by $0.11. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.38%. The company had revenue of $261.77 million for the quarter, compared to the consensus estimate of $259.52 million. During the same period in the prior year, the firm posted $2.40 EPS. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.

USNA has been the topic of several recent research reports. Pivotal Research upped their target price on shares of USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, October 25th. BidaskClub raised shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.themarketsdaily.com/2018/01/10/usana-health-sciences-inc-usna-shares-sold-by-schwab-charles-investment-management-inc.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply